A new MRM Health R&D partnership in immunotherapy points to broader clinical and investment upside.

longevity.technology/news/mrm-hea...

#longevity #Microbiome #Immunotherapy #CancerTech #BioInnovation #FutureMedicine

Breakthrough Study Shows CAR T Cells Can Be Generated Inside The Body | Cancer News A new study introduces in vivo CAR T cell generation using targeted lipid nanoparticles, offering a safer, more accessible therapy that could address cancer health disparities.

💡Game-changing #CancerTech could help close global gaps! Scientists have created CAR T cells within patients, eliminating the need for costly manufacturing and chemotherapy. This innovation could make advanced cancer care more accessible to underserved communities: buff.ly/kic6QKp #CancerNews

Bispecific Antibodies for Cancer Market Set to Reach USD 30.0 Billion, with a Healthy 12.48% CAGR Till Forecasts 2032 - Industry Today The market size reached USD 11.7 billion in 2024, up from USD 10.4 billion in 2023, and is projected to grow significantly to USD 30.0 billion by 2032

🧬🎯 #BispecificAntibodies oncology market targeting $300 B by 2032, growing at 12.48% CAGR. Next‑gen immune therapies unfolding.
#Immunotherapy #CancerTech #Biologics

industrytoday.co.uk/health_and_s...

Global AI In Oncology Market Insights 2023, Analysis And Forecast To 2030, By Component Type, By Cancer Type, By Treatment Global AI In Oncology Market, Share, Revenue, Size, Global, Research Report, Rate, Price, Industry Trends, Analysis, Outlook ,Forecast,

Discover how AI is transforming cancer care 🎗️🤖 in the global AI in Oncology Market. Explore diagnostics, treatment planning, clinical insights & future trends reshaping oncology. #AIinHealthcare #OncologyAI #CancerTech #HealthInnovation #MedicalAI 📊

Brachytherapy Market Anticipated to Reach USD 1.94 Billion, at a Notable 6.84% CAGR by 2032 | SMB in Action SMB in Action is an online news publication focusing on sme/smb in the General: Your top news on small business

💼 From clinics to markets: Brachytherapy is becoming a vital tool in oncology. $1.94B projection shows real impact. #HealthInvestment #CancerTech

www.smbinaction.com/article/7775...

Swedish Asgard Therapeutics strengthens governance and advisory capacity for AT-108 development - ArcticStartup Lund-based Asgard Therapeutics, a biotech company focused on in vivo cell reprogramming for cancer immunotherapy, has appointed Dr Cristina Csimma to its

#skanestartups #biotech company Asgard Therapeutics (@AsgardThx) strengthens governance and advisory capacity for AT-108 development. By @arcticstartup
arcticstartup.com/asgard-thera... #NordicMade #nordicbiotech #cancertech #Lundstartups

#TargetedTherapy #CancerTech #NextGenOncology #PrecisionMedicine #BigDataInHealthcare #Bioinformatics #Genomics #AIforGood #DigitalHealth #SmartMedicine #MedicalInnovation #FutureOfHealthcare #AIforCancer